Oral 22:RI Therapy・Thyroid, MIBG, Radium Chloride

[2-MO22-5] Study on FDG avidity in unresectable/metastatic PPGL treated with I-131 MIBG

Junki Takenaka^1,2、Shiro Watanabe^1,2,3、Takashige Abe⁴、Takahiro Tsuchikawa^5,6、Satoshi Takeuchi^6,7、Kenji Hirata^1,2,3,6,8、Rina Kimura^1,9、Ishii Hiroshi^1,2、Wakabayashi Naoto^1,10、Kohsuke Kudo^1,3,8,9 (1.Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Sapporo, Japan、2.Department of Nuclear Medicine, Hokkaido University Hospital, Sapporo, Japan、3.Global Center for Biomedical Science and Engineering, Faculty of Medicine, Hokkaido University, Sapporo, Japan、4.Department of Renal and Genitourinary surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan、5.Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, Sapporo, Japan、6.Center of Neuroendocrine Neoplasms, Hokkaido University Hospital, Sapporo, Japan、7.Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University、8.Division of Medical AI Education and Research, Hokkaido University Graduate School of Medicine, Sapporo, Japan、9.Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Japan、10.Department of Diagnostic Radiology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan.)